EQUI-FLUô VEWT
EQUI-FLUô VEWT
 


EQUI-FLU™ VEWT Reference Page

Description

Encephalomyelitis-Influenza Vaccine Eastern, Western, and Venezuelan, Killed Virus. Equi-FluÆ VEWT contains gentamicin and thimerosal as preservatives.

Features

Provides broad spectrum active immunity against Eastern, Western, and Venezuelan Equine Encephalomyelitis.

Provides protection against relevant strains of Equine Influenza-A1 and A2 viruses.

Contains killed viruses and tetanus toxoid.

Benefits

Safe to use on all healthy horses.

Exceptionally non-irritating at injection site.

Post-vaccination reactivity less than 1%.

Advantages

Equi-Flu VEWT is a killed virus vaccine that protects against Eastern, Western, and Venezuelan Equine Encephalomyelitis, influenza, and tetanus.

Dosage & Administration

Using aseptic technique inject 2 mL deep IM with a 11/2 inch sterile needle preferably in the hind quarters. For primary vaccination administer a second 2 mL dose in 4 to 6 weeks using a different injection site. Revaccinate annually for protection against tetanus, using a single 2 mL dose. Revaccinate annually and prior to anticipated exposure for maximum benefit against Equine Influenza strains A1 and A2 viruses and Eastern, Western, and Venezuelan Equine Encephalomyelitis.

Precautions

Store out of direct sunlight at 35∞ - 45∞ F (2∞ - 7∞ C). Shake well. Protect from freezing. Do not vaccinate within 21 days before slaughter. Anaphylactoid reactions may occur following use.
Antidote: Epinephrine.

Uses

Equi-Flu VEWT is recommended for vaccination of all types and ages of healthy horses against Eastern, Western, and Venezuelan Equine Encephalomyelitis, tetanus and as an aid in prevention of Equine Influenza strains A1 and A2.

Warning

This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy in normal healthy animals. This level of performance may be affected by conditions such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions.

Product Information

Name
Code
Size
EQUI-FLUô VEWT
131-615
2 mL 1 dose
EQUI-FLUô VEWT
131-625
20 mL 10 dose
-
-
-
-
-
-
-
-
-


Highlights

- Non-irritating.

- Sold only to licensed veterinarians.

Contact Information

Boehringer Ingelheim Vetmedica, Inc.
2621 North Belt Highway
St. Joseph, MO 64506

Information: 800-821-7467
Sales: 800-325-9167
Fax: 816-236-2717
email: techservices-ca@bi-vetmedica.com
internet: http://www.bi-vetmedica.com


General Product Information Documents

Equi-Flu VEWT General Product Information Documents
.html

.pdf

Equi-Flu VEWT Reference Page PDF
-
Equi-Flu VEWT MSDS Sheet PDF
-
Equi-Flu VEWT Product Label PDF
-


Product Photos and Product Art

Product Photos and Product Art

File Type

EQUI-FLU VEWT Photo Large
EQUI-FLU VEWT Photo Medium
EQUI-FLU VEWT Photo Small
EQUI-FLU VEWT Photo Tiff



 
Phone: 800-325-9167 | Fax: 816-236-2717 | Email | Terms of Use